Your browser doesn't support javascript.
loading
Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer.
Condorelli, M; Bruzzone, M; Ceppi, M; Ferrari, A; Grinshpun, A; Hamy, A S; de Azambuja, E; Carrasco, E; Peccatori, F A; Di Meglio, A; Paluch-Shimon, S; Poorvu, P D; Venturelli, M; Rousset-Jablonski, C; Senechal, C; Livraghi, L; Ponzone, R; De Marchis, L; Pogoda, K; Sonnenblick, A; Villarreal-Garza, C; Córdoba, O; Teixeira, L; Clatot, F; Punie, K; Graffeo, R; Dieci, M V; Pérez-Fidalgo, J A; Duhoux, F P; Puglisi, F; Ferreira, A R; Blondeaux, E; Peretz-Yablonski, T; Caron, O; Saule, C; Ameye, L; Balmaña, J; Partridge, A H; Azim, H A; Demeestere, I; Lambertini, M.
Afiliación
  • Condorelli M; Department of Obstetrics and Gynecology, Hôpital Erasme, Université Libre de Bruxelles (U.L.B.), Fertility Clinic, Brussels, Belgium; Research Laboratory on Human Reproduction, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
  • Bruzzone M; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Ceppi M; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Ferrari A; Department of Surgical Sciences, General Surgery III-Breast Surgery, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Clinical Surgical Sciences, University of Pavia, Pavia, Italy.
  • Grinshpun A; Breast Oncology Unit Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Hamy AS; Department of Medical Oncology, Institut Curie, Paris, France.
  • de Azambuja E; Department of Medicine, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
  • Carrasco E; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Peccatori FA; Gynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, Italy.
  • Di Meglio A; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.
  • Paluch-Shimon S; Breast Oncology Unit Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Poorvu PD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Venturelli M; Department of Oncology and Haematology, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.
  • Rousset-Jablonski C; Department of Surgery, Centre Léon Bérard and INSERM U1290 RESHAPE, Université Claude Bernard Lyon 1, Lyon, France.
  • Senechal C; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France.
  • Livraghi L; Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy; University of Siena, Siena, Italy.
  • Ponzone R; Gynecological Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Turin, Italy.
  • De Marchis L; Division of Medical Oncology, Department of Radiological, Oncological and Pathological Sciences, "La Sapienza" University of Rome, Rome, Italy.
  • Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Sonnenblick A; Oncology Division, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv, Israel.
  • Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.
  • Córdoba O; Obstetrics and Gynecology Department, Hospital Universitari Son Espases, Palma, Spain.
  • Teixeira L; Breast Disease Unit, Saint-Louis Hospital, APHP, Université de Paris, INSERM U976, Paris, France.
  • Clatot F; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France.
  • Punie K; Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Graffeo R; Breast Unit of Southern Switzerland (CSSI), Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Pérez-Fidalgo JA; Department of Medical Oncology, INCLIVA University Hospital of Valencia, CIBERONC, Valencia, Spain.
  • Duhoux FP; Department of Medical Oncology, Breast Clinic, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
  • Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy; Department of Medicine, University of Udine, Udine, Italy.
  • Ferreira AR; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
  • Blondeaux E; Breast Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Peretz-Yablonski T; Breast Oncology Unit Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Caron O; Department of Medical Oncology, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Saule C; Department of Genetics, Institut Curie, Paris, France.
  • Ameye L; Data Centre, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
  • Balmaña J; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
  • Azim HA; Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, Mexico.
  • Demeestere I; Department of Obstetrics and Gynecology, Hôpital Erasme, Université Libre de Bruxelles (U.L.B.), Fertility Clinic, Brussels, Belgium; Research Laboratory on Human Reproduction, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
  • Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy; Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. Electronic address: matteo.lambertini@unige.it.
ESMO Open ; 6(6): 100300, 2021 12.
Article en En | MEDLINE | ID: mdl-34775302
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Etiology_studies / Observational_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: ESMO Open Año: 2021 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Etiology_studies / Observational_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: ESMO Open Año: 2021 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido